Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and ...
Top US Food and Drug Administration (FDA) officials said the agency is open to novel, “innovative approaches” to the clinical ...
The US Food and Drug Administration (FDA) has announced the permanent appointment of four top officials to lead the agency's ...
The European Medicines Agency (EMA) has published a guidance on how companies submitting marketing authorization applications ...
Industry and patient groups have asked the US Food and Drug Administration (FDA) to make several changes to its revised draft ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The European Medicines Agency (EMA) has updated a guideline on good pharmacovigilance practice (GVP) inspections to reflect changes to the rules on subcontractors. Last year, the European Commission ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and ...
Recon: FDA approves Protagonist and Takeda’s drug for rare blood cancer; Lilly to buy Merida for up to $2.88B Join one of the ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results